Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $16 | $49 | $338 | $270 |
| - Cash | $25 | $60 | $107 | $60 |
| + Debt | $2 | $3 | $7 | $8 |
| Enterprise Value | -$8 | -$7 | $237 | $218 |
| Revenue | $0 | $10 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$1 | $8 | -$2 | -$2 |
| % Margin | – | 85.3% | – | – |
| EBITDA | -$38 | -$114 | -$88 | -$88 |
| % Margin | – | -1,165.7% | – | – |
| Net Income | -$19 | -$115 | -$89 | -$86 |
| % Margin | – | -1,180.4% | – | – |
| EPS Diluted | -7.94 | -31.16 | -26.2 | -36.5 |
| % Growth | 74.5% | -18.9% | 28.2% | – |
| Operating Cash Flow | -$44 | -$66 | -$84 | -$79 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$44 | -$66 | -$84 | -$79 |